- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01885754
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer.
Rationale: With 1.6 million new cases diagnosed each year and 1.3 million deaths, lung cancer is the leading cancer-related death worldwide and it represents a pressing health issue. Patients with lung cancer are more likely to experience cachexia, a severe debilitating disorder causing fatigue, weight loss, muscle wasting and associated with reduced physical function, increased chemotherapy toxicity and reduced survival. This syndrome occurring in about 80% of advanced cancer patients is the direct cause of death in about 20% of cases. However, despite the importance of cachexia in lung cancer, its mechanisms ans its relation with muscle function and effort tolerance are still unknown.
Aim: To explore muscle function, signaling pathways and its relationship to impaired functional capacity of patients with non-small-cell lung cancer(NSCLC); depending of whether they have cachexic state at diagnosis.
Methods: This study will be conducted at the Institut universitaire de cardiologie et de pneumologie de Québec. 56 patients newly diagnosed of NSCLC will be recruited and separated whether or not they have a cachexic state. The evaluation will need two visits separated by 5 days.
During the evaluation the following tests will be done:
- Anthropometric measures
- Level of daily physical activity
- Pulmonary function test
- Maximal incremental cardiopulmonary exercise test on ergocycle
- Endurance test on ergocycle
- Muscle function tests
- Magnetic stimulation
- Quadriceps biopsy
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
Quebec
-
Québec, Quebec, Kanada, G1V 4G5
- Rekrytering
- Institut Universitaire de cardiologie et de pneumologie de Quebec
-
Kontakt:
- Didier Saey, PhD
- Telefonnummer: 2614 418-656-8711
- E-post: didier.saey@criucpq.ulaval.ca
-
Huvudutredare:
- Didier Saey, PhD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Men and women with a primary lung cancer diagnosis
Exclusion Criteria:
- Already have undertaken surgery, chemotherapy or radiotherapy treatment
- Having an other cancer in the last five years
- Taking anticoagulation therapy
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Lung cancer patient with cachexia
Muscle lumbar area < 55cm2/m2 for men and < 39 cm2/m2 for women
|
|
Lung cancer patients without cachexia
Muscle lumbar area over 55cm2/m2 for men and 39 cm2/m2 for women
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Maximal quadriceps strength
Tidsram: 1 day (at the time of the diagnosis before any treatment)
|
1 day (at the time of the diagnosis before any treatment)
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Exercise capacity
Tidsram: 1 day (at the time of the diagnosis before any treatment)
|
1 day (at the time of the diagnosis before any treatment)
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Didier Saey, PhD, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20878
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .